Y-MABS THERAPEUTICS INC. - COMMON STOCK
10,41
22-ноября-24 16:44:58
15 мин. задержка
Акции
+0,31
+3,07%
Сегодняшний диапазон
9,93 - 10,49
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Y-mAbs Reports Third Quarter 2024 Financial Results and Recent Corporate Developments
08 ноя 2024 06:35:00 Источник Nasdaq GlobeNewswire
-
04 ноя 2024 07:35:00 Источник Nasdaq GlobeNewswire
-
Y-mAbs Announces Third Quarter 2024 Conference Call and Webcast
25 окт 2024 07:05:00 Источник Nasdaq GlobeNewswire
-
Y-mAbs to Participate in Upcoming Investor Conferences in October
01 окт 2024 07:05:00 Источник Nasdaq GlobeNewswire
-
06 сен 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Y-mAbs to Participate in Upcoming Investor Conferences in September
03 сен 2024 08:32:32 Источник Nasdaq GlobeNewswire
-
Y-mAbs Reports Second Quarter 2024 Financial Results and Recent Corporate Developments
12 авг 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
Y-mAbs to Participate in Upcoming Investor Conferences in August
07 авг 2024 07:05:00 Источник Nasdaq GlobeNewswire
-
Y-mAbs Announces Second Quarter 2024 Conference Call and Webcast
05 авг 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
Y-mAbs Appoints Seasoned Biopharma Executive Peter Pfreundschuh as Chief Financial Officer
01 июл 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
Y-mAbs Announces Preclinical GD2-SADA Data to be Presented at 2024 SNMMI Annual Meeting
07 июн 2024 07:05:00 Источник Nasdaq GlobeNewswire
-
05 июн 2024 07:05:00 Источник Nasdaq GlobeNewswire
-
Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting
01 июн 2024 08:15:00 Источник Nasdaq GlobeNewswire
-
Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting
01 июн 2024 08:05:00 Источник Nasdaq GlobeNewswire
-
Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments
07 май 2024 16:05:01 Источник Nasdaq GlobeNewswire
-
Y-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024
26 апр 2024 07:05:00 Источник Nasdaq GlobeNewswire
-
Y-mAbs to Present at 2024 ASCO Annual Meeting
25 апр 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer
14 мар 2024 09:05:00 Источник Nasdaq GlobeNewswire
-
Y-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to its Board of Directors
04 мар 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Y-mAbs Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments
29 фев 2024 16:05:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >